Altogether, data identify the DEspR+CD11b+ neutrophil-subset as a therapeutic target with the potential to break the feed-forward progression of neutrophil-mediated tissue injury in ARDS and COVID-19-ARDS, while preserving DEspR[-] neutrophil functions. The gene discussed is ITGAM; the disease is acute respiratory distress syndrome.